1. Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2
   Fei Zeng et al, 2021, International Journal of Immunopathology and Pharmacology CrossRef
2. Sirtuin 6 affects glucose reabsorption and gluconeogenesis in type 1 diabetes via FoxO1
   Che Bian et al, 2022, Molecular and Cellular Endocrinology CrossRef
3. Trimetazidine inhibits liver fibrosis and hepatic stellate cell proliferation and blocks transforming growth factor-β (TGFβ)/Smad signaling in vitro and in vivo
   Wenwen Ding et al, 2022, Bioengineered CrossRef
4. 6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in mice
   Ke Gong et al, 2023, Acta Pharmacologica Sinica CrossRef
5. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
   Adriana Romo-Perez et al, 2022, Current Molecular Pharmacology CrossRef
6. Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review
   Amalia Pușcaș et al, 2024, International Journal of Molecular Sciences CrossRef
7. The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease
   Konstantinos P. Imprialos et al, 2022, Angiology CrossRef
8. Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1–AMPK Pathway
   Xiu-ying Luo et al, 2021, Frontiers in Physiology CrossRef
9. Trimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia
   A. A. Avagimyan et al, 2022, The Siberian Journal of Clinical and Experimental Medicine CrossRef